Investors’ Patience Is Being Tested Right Now By Kintara Therapeutics Inc. (NASDAQ: KTRA)

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for Kintara Therapeutics Inc. (KTRA) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$0.0035, or -2.33%, to $0.1465. Volume reached 40,950 shares, with price reaching a high of $0.15 and a low of $0.1411. Yahoo Finance discussed the stock recently as it posted Kintara Therapeutics Announces Three Abstracts Have Been Accepted for the 2022 Society for Neuro-Oncology Annual Meeting.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now.


Stocks Info

Kintara Therapeutics Inc. is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. At the end of the last regular session, the stock closed at $0.15 and fluctuated between $0.1500 as its day high and $0.1400 as its day low. The current market capitalization of Kintara Therapeutics Inc. is $10.16M. A total of 1.04 million shares were traded on the day, compared to an average of 2.55M shares.

Insider Activity

Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, KTRA has seen 3 BUY and 0 SELL insider trades, representing the acquisition of 880,319 and the disposition of 0 shares. Over the last 12 months, there were 8 BUYs and 0 SELLs from insiders. Insiders purchased 1,017,019 shares during that period but sold 0.

In the most recent transaction, Hoffman Robert E. bought 55,000 shares of KTRA for 0.47 per share on Feb 15. After the transaction, the President and CEO now owns 55,000 company shares. In a previous transaction on Dec 08, Praill Anthony Scott bought 28,700 shares at 0.68 per share. KTRA shares that Chief Financial Officer owns now total 37,186.

Among the insiders who bought shares, Zarrabian Saiid acquired of 38,109 shares on Dec 07 at a per-share price of $0.64. This resulted in the Head of Strategic Partnerships holding 55,500 shares of KTRA after the transaction. In another insider transaction, Zarrabian Saiid bought 11,891 shares at $0.59 per share on Dec 06. Company shares held by the Head of Strategic Partnerships now total 17,391.

Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for KTRA in the last 3 months, the mean price target is $3.00 with high estimates of $3.00 and low estimates of $3.00. In terms of 52-week highs and lows, KTRA has a high of $1.53 and a low of $0.14.

As of this writing, KTRA has an earnings estimate of $-0.03 per share for the current quarter. EPS was calculated based on a consensus of 1 estimates, with a high estimate of $-0.03 per share and a lower estimate of $-0.03.

Balance Sheet Annually/Quarterly

A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information.

Analysts Opinion

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 1 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for KTRA is Buy with a score of 4.00. A total of 0 analysts rated the stock as Buy while 0 rated it as Overweight while 1 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles



The 5 Best Inflation Stocks for 2022




The 5 Best Inflation Stocks for 2022

100% free. stop anytime no spam

Get our free report on the stocks that we recommend for investors who want to protect their portfolios from inflation.